AI-Powered EHR Claims: What AI Can Actually Do in Clinical Software Today — and What It Can't

In this article

1. What "AI-powered EHR" usually means in vendor marketing
2. What AI can do reasonably well right now
3. What AI cannot reliably do yet, especially in a low-resource clinic setting
4. Why "rule-based" is not automatically inferior to "AI-based"
5. What to ask a vendor claiming "AI-powered"
6. Where Onceva fits into this
7. The honest bottom line

"AI-powered" now shows up on the homepage of most EHR vendors in Pakistan, next to feature lists that look almost identical to what they looked like two years ago. A clinic owner comparing three systems recently described the problem well: every vendor claims AI, none of them explain what the AI actually does, and the sales calls all sound the same — "smart suggestions," "intelligent workflows," "predictive insights." When she asked one vendor what the AI was trained on and how accuracy was measured, the answer was vague. When she asked another whether the AI feature had been tested on Pakistani prescribing patterns or just adapted from a US dataset, there was no clear answer either.

This is not a criticism of AI as a category. Some of it is genuinely useful. But "AI-powered" is a marketing label, not a specification, and clinics buying software need to know the difference between a feature that has been tested and validated versus one that is a wrapper around a general-purpose language model with no clinical tuning at all. This article breaks down what AI can realistically do in clinical software today, what it cannot yet do reliably, and why a plain, deterministic safety check is sometimes the more trustworthy choice — not because AI is bad, but because different problems call for different tools.

01What "AI-powered EHR" usually means in vendor marketing

The phrase gets applied to a wide range of things, and they are not equally mature. Roughly, vendor claims fall into three buckets.

• Genuinely useful, reasonably mature: ambient dictation and transcription (converting spoken consultation notes into text), administrative pattern suggestions (auto-filling common fields based on prior entries), and scheduling optimization (predicting no-show risk or suggesting appointment slots based on historical booking data).
• Emerging, useful with heavy caveats: coding and billing suggestions (suggesting ICD codes based on note text), triage chatbots for patient intake, and summarization of long patient histories.
• Marketed heavily, unproven at small-clinic scale: diagnostic AI (suggesting a diagnosis from symptoms), autonomous treatment recommendations, and predictive risk scoring for individual patients based on limited local data.

The trouble is that vendor pages rarely distinguish between these buckets. A scheduling algorithm that reduces no-shows by flagging patients with a history of missed appointments gets the same "AI-powered" badge as a feature that claims to suggest a diagnosis. One of these is a modest statistical tool. The other is a claim that, if wrong, has real clinical consequences — and in most cases has not been validated against Pakistani patient populations, local disease prevalence, or the specific way clinics here actually document visits.

02What AI can do reasonably well right now

To be fair to the technology, there are places where AI-assisted tools have moved past hype into genuine, measurable usefulness.

• Transcription and dictation. Speech-to-text has improved enough that dictating a consultation note and having it converted to structured text is a realistic time-saver, provided a clinician reviews and edits the output before it becomes part of the record.
• Administrative pattern-matching. Suggesting a likely next field value based on what thousands of similar entries have looked like (for example, common drug-dose pairings) can speed up data entry, as long as it is presented as a suggestion the user can reject, not an auto-filled fact.
• Scheduling and no-show prediction. Looking at historical booking data to flag which appointment slots are at higher risk of no-shows is a well-understood statistical problem, and clinics can benefit from it without much clinical risk if a prediction is wrong.
• Document summarization. Condensing a long chart into a shorter summary for a referring physician can save time, though it needs to be checked against the source record before being relied on for a clinical decision.

These are the categories where "AI-powered" claims are most likely to be honest and where the downside of an error is manageable — a mis-transcribed word gets caught on review, a bad scheduling suggestion wastes an appointment slot rather than harming a patient.

03What AI cannot reliably do yet, especially in a low-resource clinic setting

The claims that deserve more scrutiny are the ones with direct clinical consequences.

• Diagnostic suggestions. Models that suggest a diagnosis from symptoms are trained on datasets that may not reflect local disease prevalence, presentation patterns, or the shorthand Pakistani clinicians use in notes. A tool tuned on Western clinical text can misread abbreviations, drug names, or documentation habits that differ locally.
• Autonomous treatment recommendations. Suggesting a treatment plan without a clinician's structured input and ongoing oversight removes the accountability that clinical practice depends on. If the software is wrong, "the AI suggested it" is not a defensible position for prescribing decisions.
• Predictive risk scoring built on small, local datasets. Predictive models need volume and diversity of data to be reliable. A single clinic's patient history, or even a national dataset that has not been independently validated, is often too thin to support confident individual-level predictions.
• Replacing verification. No current AI tool, regardless of vendor claims, should be trusted to check something like a drug interaction or an allergy without a human — or without a deterministic system — verifying the underlying data first.

None of this means these tools are worthless. It means they are unproven enough, in this context, that a clinic should treat them as an assistive layer requiring human sign-off, not a replacement for clinical judgment.

04Why "rule-based" is not automatically inferior to "AI-based"

This is the point that gets lost in AI marketing: a deterministic, rule-based check against actual recorded data is not a lesser version of AI — it is a different tool built for a different job, and for some jobs it is the better one.

Take an allergy check. A rule-based system compares a new prescription against the allergies already recorded for that patient and flags a match. It does not predict, infer, or guess — it checks a fact against another fact. An AI-based version might try to infer likely allergies from a patient's history or flag "possible" interactions based on patterns learned from other patients. That sounds more sophisticated, but it introduces a layer of probability and opacity into a task that should be binary and traceable.

For a safety check specifically, this table is the whole argument. A clinic does not need software to guess whether a patient might be allergic to a drug — it needs software to check what has already been recorded and flag it reliably, every time, in a way that can be explained afterward if something goes wrong. That is a rules problem, not a prediction problem.

05What to ask a vendor claiming "AI-powered"

Before treating an "AI-powered" label as a selling point, a clinic should be able to get clear answers to:

• What specific feature is the AI powering — transcription, suggestions, diagnosis, scheduling, something else?
• What happens if the AI is wrong — is there a human review step, and is it mandatory or optional?
• What data was the model trained or validated on, and does it reflect Pakistani clinical practice?
• Is the underlying safety-critical check (allergy, interaction, dosing) AI-based or rule-based against recorded data?
• Can the vendor explain, in plain terms, why a given flag or suggestion was generated?

If a vendor cannot answer these clearly, "AI-powered" is functioning as a marketing word, not a technical description.

06Where Onceva fits into this

Onceva does not market itself as AI-powered, because it isn't. Its safety checks — allergy checking and drug interaction flagging — are rule-based: they compare a new prescription against the allergies and medications already recorded for that patient and flag a match before the prescription is issued. The same logic applies to prescribing from a DRAP-registered formulary and to the oncology record module, where BSA-based dosing and administration verification are deterministic calculations, not AI-generated recommendations. Nothing in Onceva infers, predicts, or guesses at clinical information — it checks recorded data against recorded data, consistently, and in a way that can be traced back to the source. That is a deliberate design choice, not a limitation waiting to be fixed with AI. For clinics deciding what actually matters when a vendor says "AI-powered," it's worth reading further on what AI in healthcare software can realistically deliver in Pakistan today and a direct comparison of AI-based and traditional rule-based EHR approaches. For the mechanics of how deterministic safety checks work in practice, see how drug-drug interaction checking and allergy and medication record workflows function inside a connected patient record. More educational pieces on this topic are collected in the AI & Future Healthcare Technology hub.

07The honest bottom line

"AI-powered" is not a quality signal on its own — it describes a category of technique, not a level of reliability. Some AI-assisted features, like dictation and scheduling optimization, are genuinely useful today. Others, especially anything touching diagnosis or autonomous treatment suggestions, remain unproven at the level most Pakistani clinics operate at, and should be treated with the same scrutiny as any other clinical claim: ask for evidence, ask what happens when it's wrong, and ask who is accountable for the result. A deterministic safety check that reliably compares a prescription against recorded allergies and interactions is not an old-fashioned alternative to AI — it is often the more appropriate tool for a job that needs to be predictable, auditable, and explainable every single time.

See How Onceva's Safety Checks Actually Work